Some Human Anti-Glycan Antibodies Lack the Ability to Activate the Complement System
2024

Some Human Anti-Glycan Antibodies Lack the Ability to Activate the Complement System

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Shilova Nadezhda, Nokel Alexey, Lipatnikov Alexander, Khasbiullina Nailya, Knirel Yuri, Baidakova Ludmila, Tuzikov Alexander, Khaidukov Sergei, Obukhova Polina, Henry Stephen, Shoibonov Batozhab, Salimov Emin, Rieben Robert, Bovin Nicolai, Collin Mattias, Vidarsson Gestur

Primary Institution: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science

Hypothesis

Do all human anti-glycan antibodies activate the complement system?

Conclusion

About 30% of human anti-glycan antibodies do not activate the complement system.

Supporting Evidence

  • 30% of anti-glycan antibodies did not activate the complement system.
  • Most non-activating antibodies were IgGs directed to bacterial O-antigens.
  • Complement-activating antibodies were confirmed through hemolysis tests.
  • Printed glycan arrays were used to analyze antibody specificity.
  • Antibodies to blood group systems were among those that activated complement.

Takeaway

Some antibodies in our blood can recognize germs but don't always trigger the body's defense system to fight them.

Methodology

The study used a printed glycan array to analyze the ability of human blood antibodies to activate the complement system.

Potential Biases

Potential bias in the selection of serum samples from healthy donors.

Limitations

The study only examined a limited number of donors and specific antibody types.

Participant Demographics

Five healthy adult blood donors, including both males and females, aged 31 to 56.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/antib13040105

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication